Clearstead Advisors, LLC Oric Pharmaceuticals, Inc. Transaction History
Clearstead Advisors, LLC
- $6.94 Billion
- Q2 2025
A detailed history of Clearstead Advisors, LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 4 shares of ORIC stock, worth $57. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4Holding current value
$57% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ORIC
# of Institutions
146Shares Held
91.8MCall Options Held
1.03MPut Options Held
10.1K-
Nextech Invest, Ltd. Zurich, V87.16MShares$103 Million13.76% of portfolio
-
Vr Adviser, LLC New York, NY6.6MShares$94.9 Million13.26% of portfolio
-
Viking Global Investors LP6.57MShares$94.5 Million0.21% of portfolio
-
Nextech Invest Ag5.29MShares$76 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$69.5 Million0.0% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $569M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...